NO307181B1 - Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid - Google Patents

Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid

Info

Publication number
NO307181B1
NO307181B1 NO965084A NO965084A NO307181B1 NO 307181 B1 NO307181 B1 NO 307181B1 NO 965084 A NO965084 A NO 965084A NO 965084 A NO965084 A NO 965084A NO 307181 B1 NO307181 B1 NO 307181B1
Authority
NO
Norway
Prior art keywords
cyanopyrazole
ethylacetamide
pyrimidin
phenyl
preparation
Prior art date
Application number
NO965084A
Other languages
English (en)
Other versions
NO965084D0 (no
NO965084L (no
Inventor
Thurairajah Padmanathan
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO965084D0 publication Critical patent/NO965084D0/no
Publication of NO965084L publication Critical patent/NO965084L/no
Publication of NO307181B1 publication Critical patent/NO307181B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO965084A 1995-12-01 1996-11-28 Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid NO307181B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US785995P 1995-12-01 1995-12-01

Publications (3)

Publication Number Publication Date
NO965084D0 NO965084D0 (no) 1996-11-28
NO965084L NO965084L (no) 1997-06-02
NO307181B1 true NO307181B1 (no) 2000-02-21

Family

ID=21728482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965084A NO307181B1 (no) 1995-12-01 1996-11-28 Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid

Country Status (25)

Country Link
US (1) US5714607A (no)
EP (1) EP0776898B1 (no)
JP (1) JP4112032B2 (no)
KR (1) KR100439282B1 (no)
CN (1) CN1057525C (no)
AR (1) AR004822A1 (no)
AT (1) ATE227290T1 (no)
AU (1) AU718310B2 (no)
BR (1) BR9605760A (no)
CA (1) CA2191647C (no)
CY (1) CY2440B1 (no)
CZ (1) CZ292253B6 (no)
DE (1) DE69624657T2 (no)
DK (1) DK0776898T3 (no)
ES (1) ES2184844T3 (no)
HU (1) HU226398B1 (no)
IL (1) IL119710A (no)
MX (1) MX9605974A (no)
NO (1) NO307181B1 (no)
NZ (1) NZ299848A (no)
PT (1) PT776898E (no)
RU (1) RU2178415C2 (no)
SK (1) SK281807B6 (no)
TW (1) TW382629B (no)
ZA (1) ZA9610008B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1305315A2 (en) * 2000-08-03 2003-05-02 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
EP1526136A1 (en) * 2000-08-03 2005-04-27 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
AR029780A1 (es) 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
TR200402588T3 (tr) * 2001-06-12 2004-11-22 Biogal Gyogyszergyar Rt N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi
JP2005523874A (ja) 2001-08-01 2005-08-11 テバ ジョジセルジャール レースベニュタールシャシャーグ Ｎ−〔３−（３−シアノピラゾロ〔１，５−ａ〕ピリミジン−７−イル）フェニル〕−Ｎ−エチルアセタミド（ザレプロン）の精製方法、及び当該方法により得られうるザレプロンの結晶型
EP1476446B1 (de) * 2002-02-14 2007-08-01 Cilag AG Verfahren zur herstellung von n-ethyl-n-(3-(3-cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)-acetamid
ZA200406577B (en) * 2002-02-15 2006-06-28 Teva Gyogyzeryan Reszvenytarsa Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu
DE112004001615T5 (de) 2003-09-04 2006-06-14 Cipla Ltd. Zaleplon-Synthese
EP2343073A3 (en) 2003-12-11 2011-10-12 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
JP2007517876A (ja) * 2004-01-14 2007-07-05 マリンクロッド・インコーポレイテッド 選択的ピラゾロピリミジン類の合成のための２相法
HUP0400325A3 (en) * 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
AU2005215376B2 (en) 2004-02-18 2011-01-20 Sunovion Pharmaceuticals Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon
US7652018B2 (en) * 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
WO2008068600A2 (en) * 2006-12-06 2008-06-12 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of zaleplo
CZ2008468A3 (cs) 2008-07-31 2009-11-18 Farmak, A. S. Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法
CN112694336B (zh) * 2020-12-29 2021-11-16 哈尔滨工业大学 一种高纯α相氮化硅纤维毡的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
JPS62270584A (ja) * 1986-04-28 1987-11-24 Yoshitomi Pharmaceut Ind Ltd ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
HUP9603275A3 (en) 1997-10-28
HU9603275D0 (en) 1997-01-28
CZ292253B6 (cs) 2003-08-13
HU226398B1 (en) 2008-11-28
DK0776898T3 (da) 2003-02-24
CA2191647C (en) 2005-01-25
AU7409196A (en) 1997-06-05
NZ299848A (en) 1998-09-24
US5714607A (en) 1998-02-03
EP0776898A1 (en) 1997-06-04
KR970042543A (ko) 1997-07-24
DE69624657D1 (de) 2002-12-12
ZA9610008B (en) 1998-08-28
JP4112032B2 (ja) 2008-07-02
IL119710A (en) 1999-11-30
ATE227290T1 (de) 2002-11-15
CN1057525C (zh) 2000-10-18
PT776898E (pt) 2003-02-28
DE69624657T2 (de) 2003-08-21
EP0776898B1 (en) 2002-11-06
CZ350596A3 (en) 1997-09-17
IL119710A0 (en) 1997-02-18
RU2178415C2 (ru) 2002-01-20
NO965084D0 (no) 1996-11-28
HUP9603275A2 (en) 1997-08-28
SK153696A3 (en) 1997-11-05
CY2440B1 (en) 2004-11-12
AU718310B2 (en) 2000-04-13
BR9605760A (pt) 1998-08-25
TW382629B (en) 2000-02-21
CA2191647A1 (en) 1997-06-02
NO965084L (no) 1997-06-02
CN1163893A (zh) 1997-11-05
SK281807B6 (sk) 2001-08-06
AR004822A1 (es) 1999-03-10
ES2184844T3 (es) 2003-04-16
JPH09216885A (ja) 1997-08-19
KR100439282B1 (ko) 2004-08-31
MX9605974A (es) 1998-04-30

Similar Documents

Publication Publication Date Title
NO307181B1 (no) Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid
NO973982D0 (no) Fremgangsmåte for fremstilling av heteromultimere polypeptider
PL320555A1 (en) Method of obtaining 5-[2-ethoxy-5-(4-methylpierazin-1-ylsulphonyl)phenyl]-1-methyl-3-n-propylo-1,6-dihydro-7h-pyrazole[4,3-d]pyrimidin-7-one and novel intermediate compounds
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO306620B1 (no) Fremgangsmåte for fremstilling av polydimetylsiloksaner
EE04192B1 (et) Pürasolo[4,3-d]pürimidiin-7-oonide ja nende vaheühendite valmistamise protsess
FI981709A0 (fi) Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi
BR9605030A (pt) Processo para derivados de 4H-imidazol [1, 5-a][1, 4] benzodiazepina
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
PL327539A1 (en) 2,7-substituted derivatives of octahydropyrrole[1,2-a]-pyrazine
AU3207297A (en) Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo{1,5-a}benzod iazepine
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
GB9410441D0 (en) Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation
IL150163A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND SOME NOVEL SUCH COMPOUNDS
EG22775A (en) Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof
NO963432D0 (no) Fremgangsmåte for fremstilling av dimetyldiklorsilan
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO305803B1 (no) Forbedret fremgangsmÕte for fremstilling av 2-amino-3,5-dihydro-7-substituerte 4H-pyrrolo [3,2-d]-pyrimidin-4-oner
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO20016271D0 (no) Fremgangsmåte for fremstilling av substituerte [1,4]diazepino[6,7,1-hi]indol-4-oner
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
NO964146L (no) Fremgangsmåte for fremstilling av 5-substituerte pyrrolo(2,3-d)pyrimidiner
EE03376B1 (et) Meetod ravimuda ettevalmistamiseks
GB0110251D0 (en) Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof

Legal Events

Date Code Title Description
MK1K Patent expired